ETHOS RESEARCH AND DEVELOPMENT, LLC

Medtech · Private

Urine-based biomarker assay using LC-MS/MS to detect inflammatory and non-inflammatory pathologies in systemic juvenile idiopathic arthritis, paired with software-based clinical decision support for t

Grants
$225K
1 award
Sector median: 1
Raised
—
No Form D on record
Contracts
—
No federal contracts on record
Patents
—
No published records under this name
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Federal grantDepartment of Health and Human Services · Phase I · Development of a urinary biomarker panel and software-based solutions to optimize treatment strategies for Systemic Juvenile Idiopathic Arthritis.$224,592
Federal grant · SBIR/STTR

Peer position

Medtech · 4531 companies · ranked on federal contract value
Medtech companies ranked by federal contract value
#CompanyContractsDisclosed equity
1232RADOM CORPORATION—$6.2M
1233A-SYNAPTIC CORP.—$1.7M
1234Anumana, Inc.—$32M
1235ETHOS RESEARCH AND DEVELOPMENT, LLC——
1236Scanadu Inc—$45M
1237Liquid Lung DX, Inc.—$70K
1238ADVANCED MEDICAL DEVICE TECHNOLOGIES, INC.——

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.